You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

virological relapse

Showing 1 - 25 of 4,156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Safety and Biomarkers of Bulevirtide Treatment in Chronic

Recruiting
  • Chronic Hepatitis D
  • Stockholm, Sweden
    Karolinska University Hospital, Department of Infectious Disease
Sep 27, 2023

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

Kidney Transplant Infection Trial in Bordeaux, Lyon (Group 1_No proph treatment, Group 2A_Proph treatment and ?d T cell

Completed
  • Kidney Transplant Infection
  • Group 1_No proph treatment
  • +2 more
  • Bordeaux, France
  • +1 more
Jun 4, 2021

Hepatitis B, Chronic Trial in Daegu, Seoul, Ulsan (Stop group)

Recruiting
  • Hepatitis B, Chronic
  • Stop group
  • Daegu, Korea, Republic of
  • +9 more
May 11, 2022

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ

Not yet recruiting
  • Cytomegalovirus Infections
  • Solid Organ Transplantation
    • Bordeaux, France
    • +6 more
    Jan 17, 2023

    Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

    Not yet recruiting
    • Hepatitis B, Chronic
    • Shanghai, Shanghai, China
      Shanghai Tong Ren Hospital
    Nov 12, 2021

    Different Antiviral Regimens for Hepatitis C Virus Relapse

    Unknown status
    • Hepatitis C
    • +2 more
    • directly acting antivirals
    • Alexandria, Egypt
      Alexandria University.
    Dec 4, 2020

    After Long-Term Antiviral Treatment for Chronic Hepatitis B

    Completed
    • Chronic Hepatitis B e Antigen Positive
    • Chronic Hepatitis B e Antigen Negative
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Switch From Etravirine to Doravirine asPart of Antiretroviral

      Not yet recruiting
      • HIV Infections
        • (no location specified)
        Nov 24, 2023

        Chronic Hepatitis b, Hepatitis B Reactivation Trial in Taiwan (Vemlidy)

        Recruiting
        • Chronic Hepatitis b
        • Hepatitis B Reactivation
        • Chiayi City, Taiwan
        • +6 more
        Aug 4, 2021

        Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

        Completed
        • Hepatitis C
        • Bradford, United Kingdom
        • +3 more
        Jan 4, 2023

        Chronic Hepatitis B Virus Infection Manage

        Completed
        • Chronic HBV Infection
        • Drug Withdrawal
        • serum HBV RNA
        • (no location specified)
        Jan 30, 2021

        Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

        Completed
        • Chronic Hepatitis c Genotype 1
        • Moscow, Russian Federation
        • +4 more
        Oct 27, 2022

        Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +5 more
        • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
        • (no location specified)
        Aug 23, 2022

        Chronic Hepatitis b Trial in Lyon (procedure, biological, other)

        Not yet recruiting
        • Chronic Hepatitis b
        • Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique
        • +2 more
        • Lyon, France
          Hepatology Department - Hospices Civils de Lyon
        Sep 14, 2023

        Study on Infectious Mononucleosis in Munich

        Completed
        • Infectious Mononucleosis
        • Epstein-Barr Virus Infections
          • Munich, Bavaria, Germany
            MRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
          Aug 16, 2023

          HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

          Recruiting
          • HIV/AIDS
          • Antwerp, Belgium
          • +47 more
          Jan 9, 2023

          Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood

          Not yet recruiting
          • Hepatitis B, Chronic
          • Detection of HBV-DNA in Peripheral Blood Mononuclear cells
          • (no location specified)
          Dec 13, 2021

          Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

          Recruiting
          • Chronic Hepatitis C
          • Chronic Hepatitis B
          • Tenofovir Alafenamide 25 MG
          • Sofosbuvir / Velpatasvir
          • Beijing, Beijing, China
            Peking University First Hospital
          Aug 2, 2021

          Chronic Hepatitis Trial in Italy (Peginterferon alpha-2a + Ribavirin)

          Completed
          • Chronic Hepatitis
          • Peginterferon alpha-2a + Ribavirin
          • Avellino, Italy
          • +34 more
          Mar 9, 2022

          Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))

          Recruiting
          • Hepatitis C Virus (HCV)
          • Glecaprevir/Pibrentasvir (GLE/PIB)
          • Chandler, Arizona
          • +62 more
          Aug 8, 2022

          HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

          Recruiting
          • HIV-1-infection
          • B/F/TAF
          • TDF-based triple ART regimen switching to B/F/TAF
          • Shanghai, Shanghai, China
          • +2 more
          Dec 1, 2022

          Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

          Active, not recruiting
          • Chronic Hepatitis b
          • Nuc Discontinuation
          • Entecavir or Tenofovir
          • Chiayi City, Taiwan
          • +5 more
          Mar 30, 2023